Miami, FL — (ReleaseWire) — 01/14/2015 — Investing in marijuana stocks as been referred to in the past as the “green rush”, especially after Colorado and Washington became the first states to legalize recreational cannabis. Businesses with no experience in the cannabis circuit were trying to move in to make some green of their own. Savvy penny stock investors soon […]
Watch tonight’s video market recap on my Ticker.tv channel, Mark333.Indexes continued their rotten start to 2015 as the S&P 500 fell 0.89% and the NASDAQ 1.29%. Markets opened up and then sellers came in which is not the type of action you want to see during a bull market move – you want the opposite (morning weakness bought!). Oil continues […]
Google: From Internet Search to Cancer Search | Wall Street Daily
© 2014 Wall Street Daily, LLC. All rights reserved.105 West Monument Street, Baltimore, MD 21201T. 855.405.3939 or 443.353.4052 F. 410.246.2297
Newsletter FAQ | Cancel Any Time | We Value Your Privacy
Close
Link to original:
A New Google Search: The Hunt for Cancer
See which stocks are being affected by Social Media
[…]
Source: Celgene Corp.The volatility that comes with investing in biotech stocks can test the patience of even the most risk-tolerant investor. Many investors may be better served focusing on companies with proven track records of success rather than concentrating on emerging biotech stocks that are more promise than profit. Fortunately, investing in proven performers doesn’t have to mean sacrificing growth! […]
Coral Gables, FL / ACCESSWIRE / October 28, 2014 / CytRx Corporation (NASDAQ: CYTR) announced that a paper, titled “A Phase 1b/2 Study of Aldoxorubicin in Patients With Soft Tissue Sarcoma,” has been published online in Cancer, the prestigious, peer-reviewed journal of the American Cancer Society.The paper discusses results from CytRx’s completed Phase 1b/2 clinical trial where 25 patients were […]
Once again, deals and collaborations made news in the biotech sector with BioMarin (BMRN – Analyst Report) announcing its intention to acquire Prosensa (RNA – Snapshot Report) and Five Prime Therapeutics (FPRX – Snapshot Report) signing a second immuno-oncology focused deal with Bristol-Myers Squibb.Meanwhile, AbbVie (ABBV – Analyst Report) continues to progress with its hepatitis C virus (HCV) treatment with […]
I’m too depressed this morning to write anything useful.Yesterday I “visited” my bank safety deposit box and leafed through a pile of share certificates. There was the magazine that went broke. There were the many biotech drugs that failed their human trials and never got FDA approval. There’s the New England bank that’s actually doing well but refuses to pay […]
Over the summer, I’ve given many lectures about SMAC – social media, mobile, analytics and cloud computing.The most popular analytics topics are business intelligence, big data, and novel data visualizations.Recently, Dr. Chris Longhurst, chief medical information officer at Lucile Packard Children’s Hospital, and colleagues wrote an article in the Big Data Issue of Health Affairs, that suggests a very practical […]
Researchers at IBM, Berg Pharma, Memorial Sloan Kettering, UC Berkeley and other institutions are exploring how artificial intelligence and big data can be used to develop better treatments for diseases (as we explored in a separate story on Saturday).But one of the biggest challenges for making full use of these computational tools in medicine is that vast amounts of data have been locked away — or never […]
What is ‘big data’?Data is everywhere. It affects what you eat and how you drive; it powers our towns and shapes our economy. And one day it may help keep you alive.And as computers have got more powerful and sophisticated, we can now combine huge amounts of data together to generate even deeper insights about the world around us.Welcome to […]
